Analysis

Johnson & Johnson heads into Q4 as a more focused healthcare leader

Johnson & Johnson (NYSE: JNJ) is capitalizing on its transition from a broad-based healthcare conglomerate into a market leader in innovative medicine

Banks Earnings Preview: Top banks set to report Q4 2025 earnings results this week

A number of major banks are set to publish their earnings results for the fourth quarter of 2025 this week. While JPMorgan

Shifting demand and margins in focus as Fastenal (FAST) prepares for Q4 report

Fastenal Company (NASDAQ: FAST) is gearing up to publish its fourth-quarter 2025 financial results, after effectively navigating an evolving market environment. The report

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

Shifting demand and margins in focus as Fastenal (FAST) prepares for Q4 report

Fastenal Company (NASDAQ: FAST) is gearing up to publish its fourth-quarter 2025 financial results, after effectively navigating an evolving market environment. The report is expected to shed light on the company's

January 9, 2026

Constellation Brands (STZ) gets through another difficult quarter with few gains

Shares of Constellation Brands (NYSE: STZ) stayed red on Friday. The stock has gained 4% in the past three months. The beverage company saw its sales and profits decline in

January 9, 2026

Earnings Preview: What to look for when Netflix (NFLX) reports Q4 2025 results

Netflix, Inc. (NASDAQ: NFLX) is expected to report Q4 results on January 20, amid expectations for strong revenue and earnings growth. The company is navigating a shifting streaming landscape where

January 8, 2026

Research Summary

SentinelOne, Inc. (NYSE: S) Research Summary

SentinelOne, Inc. (NYSE: S) is a leading cybersecurity company that offers advanced threat protection

Ocean Biomedical (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech company focused on moving new

Viewing Highlight
Loading...
Highlight
Close
Top